Medifast

MED · NYSE

$12.06+$0.03 (+0.25%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $12.03

MED analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold1
Underperform0
Sell0

12-month price target · 2 analysts

Average $12.24 (+1.5% upside)

Low: $12.12
Now: $12.06
High: $12.60

Upgrades and downgrades

The latest rating actions, newest first

MED analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Stephens & Co.	Feb 19, 2026	Maintains	Equal-Weight	$15.00 → $12.00	24%

The case for and against

Updated Apr 24, 2025

Bull case

Medifast Inc. has reported an encouraging increase in engagement metrics on its newly enhanced website, specifically highlighting a double-digit rise in average session time, which suggests growing interest in its products. The company is optimistic about potential improvement in sales per Coach in 4Q25 and anticipates a resumption of year-over-year growth in Coach numbers in the first half of 2026, fueled by signs of recovery in key underlying metrics. Additionally, Medifast has achieved significant cost savings and is poised for a projected sales growth of 6% year-over-year in 2026, reinforcing its commitment to delivering value to its stakeholders.

Bear case

Medifast Inc.'s financial outlook remains negative due to declining sales estimates, with a reduction in full-year sales projections to -21% year-over-year and a forecast of flat sales for the fourth quarter of 2025. The company's operating margin has significantly decreased to 0.6%, demonstrating a challenging cost structure amidst lower-than-expected return on investment and reduced advertising expenditures. Additionally, free cash flow has sharply decreased, projected at less than $30 million for 2024 compared to $138 million in 2023, raising concerns about financial sustainability without substantial cost-cutting measures implemented.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.